High On Positive News: Agios Pharmaceuticals (AGIO), Janus Capital Group (JNS), Natural Alternatives (NAII)

Albany, New York (09/26/2014) – There is nothing to hold back Agios Pharmaceuticals Inc (NASDAQ:AGIO). The stock is surging and reached a new 12-month high of $66.98 amid heavy volume early Friday. That happened as investor confidence in the $2.22 billion biopharmaceutical company seemed to firm up. The excitement around the stock can be traced to the positive comments from analysts. There have been positive comments around the stock since Agios Pharmaceuticals Inc (NASDAQ:AGIO) announced an upcoming presentation of clinical trial results from its efforts in cancer treatment. Phase 1 trial data on AG-120 will be highlighted at a cancer event in Barcelona, Spain on November 18-21. Agios Pharmaceuticals Inc (NASDAQ:AGIO) reported revenue of $8.41 million in the most recent quarter. The figure was up more than 33% from the previous year.

Janus Capital Group Inc (NYSE:JNS) has attracted bond guru in the person of Bill Gross, who leaves PIMCO to join the $2.7 billion mutual fund management firm. Shares of the firm rose to a new 12-month high of $15.65 on the hiring news, a sign that investors hope for the best with Gross at Janus. The exit of Gross from PIMCO, the largest bond firm in the world, comes at a time when recent reports cited his clash with other executives there. The financial performance of Janus Capital Group Inc (NYSE:JNS) in the most recent quarter was a source of inspiration by most measures. The firm reported EPS of $0.19, ahead of the estimate of $0.18. Revenue was $231.20 million, 7.1% better than the same quarter a year ago. However, revenue fell short of $235.07 million that analysts sought for the quarter.

Natural Alternatives International, Inc. (NASDAQ:NAII) shot up to a new 12-month high of $6.64 on the back of positive earnings news. The company reported 4Q net sales of $21.2 million, 26% better than the comparable quarter a year ago. The increase in net sales in the quarter was attributed to the high sales volume, new products and new customer acquisitions. Natural Alternatives International, Inc. (NASDAQ:NAII) recorded 4Q net income as $1.1 million or $0.16 per share, better than $0.09 per share a year ago.

About the Author

Coper graduated from the University of Chicagi with majors in political science and journalism.

Leave A Response